These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28888772)

  • 1. Re: Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology: A. Priester, S. Natarajan, P. Khoshnoodi, D. J. Margolis, S. S. Raman, R. E. Reiter, J. Huang, W. Grundfest and L. S. Marks J Urol 2017;197:320-326.
    Orczyk C; Emberton M
    J Urol; 2017 Dec; 198(6):1436-1437. PubMed ID: 28888772
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology: A. Priester, S. Natarajan, P. Khoshnoodi, D. J. Margolis, S. S. Raman, R. E. Reiter, J. Huang, W. Grundfest and L. S. Marks J Urol 2017;197:320-326.
    Yan W; Shang Z; Zhou Z
    J Urol; 2017 Sep; 198(3):708-709. PubMed ID: 28577379
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient-specific Molds to Correlate Images with Whole-mount Pathology.
    van der Kwast T
    Eur Urol; 2018 Jan; 73(1):139. PubMed ID: 29042126
    [No Abstract]   [Full Text] [Related]  

  • 4. Magnetic Resonance Imaging Underestimation of Prostate Cancer Geometry: Use of Patient Specific Molds to Correlate Images with Whole Mount Pathology.
    Priester A; Natarajan S; Khoshnoodi P; Margolis DJ; Raman SS; Reiter RE; Huang J; Grundfest W; Marks LS
    J Urol; 2017 Feb; 197(2):320-326. PubMed ID: 27484386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer: S. Loeb, M. G. Sanda, D. L. Broyles, S. S. Shin, C. H. Bangma, J. T. Wei, A. W. Partin, G. G. Klee, K. M. Slawin, L. S. Marks, R. H. N. van Schaik, D. W. Chan, L. J. Sokoll, A. B. Cruz, I. A. Mizrahi and W. J. Catalona J Urol 2015;193:1163-1169.
    Shah N; Ioffe V
    J Urol; 2015 Dec; 194(6):1825-6. PubMed ID: 26354886
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: The Institutional Learning Curve of Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy: Temporal Improvements in Cancer Detection in 4 Years
    Oefelein MG
    J Urol; 2019 Jun; 201(6):1209-1211. PubMed ID: 30896277
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study: J. E. Thompson, D. Moses, R. Shnier, P. Brenner, W. Delprado, L. Ponsky, M. Pulbrook, M. Böhm, A.-M. Haynes, A. Hayen and P. D. Stricker J Urol 2014;192:67-74.
    El-Shater Bosaily A; Arya M; Punwani S; Emberton M; Kirkham A; Freeman A; Ahmed HU
    J Urol; 2015 Feb; 193(2):735-6; discussion 736. PubMed ID: 25445580
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of magnetic resonance image guided prostate biopsy in stratifying men for risk of extracapsular extension at radical prostatectomy. Raskolnikov D, George AK, Rais-Bahrami S, Turkbey B, Siddiqui MM, Shakir NA, Okoro C, Rothwax JT, Walton-Diaz A, Sankineni S, Su D, Stamatakis L, Merino MJ, Choyke PL, Wood BJ, Pinto PA. Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Center for Interventional Oncology, National Cancer Institute & Clinical Center, National Institutes of Health, Bethesda, Maryland; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Center for Interventional Oncology, National Cancer Institute & Clinical Center, National Institutes of Health, Bethesda, Maryland; e-mail: pintop@mail.nih.gov.J Urol. 2015 Jul;194(1):105-11. [Epub 2015 Jan 23]. doi: 10.1016/j.juro.2015.01.072.
    Scott E
    Urol Oncol; 2017 Mar; 35(3):121. PubMed ID: 28159491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Timing of Adverse Prostate Cancer Reclassification on First Surveillance Biopsy: Results from the Canary Prostate Cancer Active Surveillance Study: L. C. Macleod, W. J. Ellis, L. F. Newcomb, Y. Zheng, J. D. Brooks, P. R. Carroll, M. E. Gleave, R. S. Lance, P. S. Nelson, I. M. Thompson, Jr., A. A. Wagner, J. T. Wei and D. W. Lin J Urol 2017;197:1026-1033.
    Denize J; Nouhaud FX; Cornu JN; Pfister C
    J Urol; 2017 Sep; 198(3):709-711. PubMed ID: 28579000
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Smaller prostate size predicts high grade prostate cancer at final pathology. M. R. Newton, S. Phillips, S. S. Chang, P. E. Clark, M. S. Cookson, R. Davis, J. H. Fowke, S. D. Herrell, R. Baumgartner, R. Chan, V. Mishra, J. D. Blume, J. A. Smith, Jr. and D. A. Barocas. J Urol 2010; 184: 930-937.
    Calışkan S
    J Urol; 2011 Apr; 185(4):1537-8; author reply 1538. PubMed ID: 21349547
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: A systematic review of vitamin D receptor gene polymorphisms and prostate cancer risk. S. I. Berndt, J. L. Dodson, W. Y. Huang and K. K. Nicodemus, J Urol 2006; 175: 1613-1623.
    Rukin NJ; Luscombe CJ; Strange RC
    J Urol; 2007 Jan; 177(1):404. PubMed ID: 17162099
    [No Abstract]   [Full Text] [Related]  

  • 12. A system using patient-specific 3D-printed molds to spatially align in vivo MRI with ex vivo MRI and whole-mount histopathology for prostate cancer research.
    Wu HH; Priester A; Khoshnoodi P; Zhang Z; Shakeri S; Afshari Mirak S; Asvadi NH; Ahuja P; Sung K; Natarajan S; Sisk A; Reiter R; Raman S; Enzmann D
    J Magn Reson Imaging; 2019 Jan; 49(1):270-279. PubMed ID: 30069968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Prostate cancer severity among low income, uninsured men. D. C. Miller, M. S. Litwin, J. Bergman, S. Stepanian, S. E. Connor, L. Kwan and W. J. Aronson. J Urol 2009; 181: 579-584.
    Watson RA
    J Urol; 2010 Mar; 183(3):1259-60; author reply 1260. PubMed ID: 20097378
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?: A. Walton Diaz, A. N. Hoang, B. Turkbey, C. W. Hong, H. Truong, T. Sterling, S. Rais-bahrami, M. M. Siddiqui, L. Stamatakis, S. Vourganti, J. Nix, J. Logan, C. Harris, M. Weintraub, C. Chua, M. J. Merino, P. Choyke, B. J. Wood and P. A. Pinto J Urol 2013; 190: 2020-2025.
    Goel MC
    J Urol; 2015 Apr; 193(4):1444-6. PubMed ID: 25582380
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection. S. J. Freedland, E. A. Platz, J. C. Presti Jr., W. J. Aronson, C. L. Amling, C. J. Kane and M. K. Terris. J Urol, 175: 500-504, 2006.
    Stamatiou K; Alevizos A; Mariolis A; Sofras F
    J Urol; 2006 Sep; 176(3):1251-2; author reply 1252. PubMed ID: 16890735
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy: A. R. Rastinehad, B. Turkbey, S. S. Salami, O. Yaskiv, A. K. George, M. Fakhoury, K. Beecher, M. A. Vira, L. R. Kavoussi, D. N. Siegel, R. Villani and E. Ben-Levi. J Urol 2014; 191: 1749-1754.
    Patodia M; Goel A; Kumar M
    J Urol; 2014 Dec; 192(6):1888; discussion 1888-9. PubMed ID: 25194541
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Risk Stratification of Equivocal Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate: T. Ullrich, M. Quentin, C. Arsov, A. K. Schmaltz, A. Tschischka, N. Laqua, A. Hiester, D. Blondin, R. Rabenalt, P. Albers, G. Antoch and L. Schimmöller J Urol 2018;199:691-698.
    Scialpi M; D'Andrea A; Aisa MC; Malaspina CM
    J Urol; 2018 Jul; 200(1):202-204. PubMed ID: 29596804
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era: A. S. Kibel, J. P. Ciezki, E. A. Klein, C. A. Reddy, J. D. Lubahn, J. Haslag-minoff, J. O. Deasy, J. M. Michalski, D. Kallogjeri, J. F. Piccirillo, D. M. Rabah, C. Yu, M. W. Kattan And A. J. Stephenson; J Urol 2012; 187: 1259-1265.
    Stenmark MH; Hamstra DA
    J Urol; 2012 Dec; 188(6):2438-9; author reply 2439-40. PubMed ID: 23088984
    [No Abstract]   [Full Text] [Related]  

  • 19. Improved Magnetic Resonance Imaging-Pathology Correlation With Imaging-Derived, 3D-Printed, Patient-Specific Whole-Mount Molds of the Prostate.
    Costa DN; Chatzinoff Y; Passoni NM; Kapur P; Roehrborn CG; Xi Y; Rofsky NM; Torrealba J; Francis F; Futch C; Hagens P; Notgrass H; Otero-Muinelo S; Pedrosa I; Chopra R
    Invest Radiol; 2017 Sep; 52(9):507-513. PubMed ID: 28379863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR Study: S. Avulova, Z. Zhao, D. Lee, L. C. Huang, T. Koyama, K. E. Hoffman, R. M. Conwill, X. C. Wu, V. Chen, M. R. Cooperberg, M. Goodman, S. Greenfield, A. S. Hamilton, M. Hashibe, L. E. Paddock, A. Stroup, M. J. Resnick, D. F. Penson and D. A. Barocas J Urol 2018;199:1202-1209.
    Ramakrishnan VM; Bossert K; Lehmann KH; Hefermehl LJ
    J Urol; 2018 Nov; 200(5):1124-1125. PubMed ID: 30059667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.